Reporting number needed to treat and absolute risk reduction in randomized controlled trials

被引:136
作者
Nuovo, J [1 ]
Melnikow, J [1 ]
Chang, D [1 ]
机构
[1] Univ Calif Davis, Dept Family & Community Med, Sacramento, CA 95817 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2002年 / 287卷 / 21期
关键词
D O I
10.1001/jama.287.21.2813
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Ongoing efforts to improve the quality of reporting for randomized controlled trials (RCTs) include the Consolidated Standards of Reporting Trials (CONSORT) statement. We examined the frequency of explicit reporting of the number needed to treat (NNT) and the absolute risk reduction (ARR) in RCTs. Methods Five frequently cited journals were investigated: Annals of Internal Medicine, BMJ, JAMA, The Lancet, and the New England Journal of Medicine. For each journal, 4 years were evaluated: 1989, 1992, 1995, and 1998. All issues of each journal for each year were reviewed manually. Eligible articles were those in which an RCT was conducted on the use of a medication showing a significant treatment effect. Elements abstracted from each eligible article were the condition investigated, event being treated or prevented, intervention, study results, and reporting methods (relative risk reduction, NNT, and ARR). Results Of 359 eligible articles, NNT was reported in 8 articles. Six of the 8 studies were from 1998. Absolute risk reduction was reported in 18 articles, 10 of which were from 1998. Conclusions Despite CONSORT recommendations, few authors expressed their findings in terms of NNT or ARR. Consideration should be given to including these values in reports of RCTs.
引用
收藏
页码:2813 / 2814
页数:2
相关论文
共 12 条
  • [1] The revised CONSORT statement for reporting randomized trials: Explanation and elaboration
    Altman, DG
    Schulz, KF
    Moher, D
    Egger, M
    Davidoff, F
    Elbourne, D
    Gotzsche, PC
    Lang, T
    [J]. ANNALS OF INTERNAL MEDICINE, 2001, 134 (08) : 663 - 694
  • [2] Improving the quality of reporting of randomized controlled trials - The CONSORT statement
    Begg, C
    Cho, M
    Eastwood, S
    Horton, R
    Moher, D
    Olkin, I
    Pitkin, R
    Rennie, D
    Schulz, KF
    Simel, D
    Stroup, DF
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (08): : 637 - 639
  • [3] Chatellier G, 1996, BRIT MED J, V312, P426
  • [4] THE NUMBER NEEDED TO TREAT - A CLINICALLY USEFUL MEASURE OF TREATMENT EFFECT
    COOK, RJ
    SACKETT, DL
    [J]. BRITISH MEDICAL JOURNAL, 1995, 310 (6977) : 452 - 454
  • [5] Value of flow diagrams in reports of randomized controlled trials
    Egger, M
    Jüni, P
    Bartlett, C
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (15): : 1996 - 1999
  • [6] Influence of data display formats on physician investigators' decisions to stop clinical trials: prospective trial with repeated measures
    Elting, LS
    Martin, CG
    Cantor, SB
    Rubenstein, EB
    [J]. BRITISH MEDICAL JOURNAL, 1999, 318 (7197) : 1527 - 1531
  • [7] Putting trials on trial - the costs and consequences of small trials in depression: a systematic review of methodology
    Hotopf, M
    Lewis, G
    Normand, C
    [J]. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 1997, 51 (04) : 354 - 358
  • [8] Adherence to published standards of reporting - A comparison of placebo-controlled trials published in English or German
    Junker, CA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (03): : 247 - 249
  • [9] AN ASSESSMENT OF CLINICALLY USEFUL MEASURES OF THE CONSEQUENCES OF TREATMENT
    LAUPACIS, A
    SACKETT, DL
    ROBERTS, RS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (26) : 1728 - 1733
  • [10] Use of the CONSORT statement and quality of reports of randomized trials - A comparative before-and-after evaluation
    Moher, D
    Jones, A
    Lepage, L
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (15): : 1992 - 1995